Skip to main content
. 2023 Nov 6;42(3):312–323. doi: 10.1200/JCO.23.00236

FIG 4.

FIG 4.

(A) PFS and (B) OS by treatment allocation among the IMDC intermediate-/poor-risk population. IMDC, International Metastatic Renal Cell Carcinoma Database Consortium; NR, not reached; OS, overall survival; PFS, progression-free survival.